Status:
COMPLETED
Sacral Erector Spinae Block for Pilonidal Sinus Surgery
Lead Sponsor:
Menoufia University
Conditions:
Post Operative Pain
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The incidence of pilonidal sinus disease (PD) is estimated to be around 26/100,000 individuals mostly men.PD can cause the development of abscess or a draining sinus tract and that may lead to a loss ...
Detailed Description
Sacral erector spinae plane block was first described by Tulgar et al. To provide sensory blockade in the parasacral region in two cases who had pilonidal sinus surgeries. Since then, the block was us...
Eligibility Criteria
Inclusion
- Age \>18 years old
- ASA physical status 1-3
Exclusion
- ASA \>3
- Opioid use within the previous 3 months
- Deranged coagulation parameters
- Patient refusal
- Allergy to local anesthetic medication.
- Preoperative neurological deficits
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT06577064
Start Date
November 1 2023
End Date
August 1 2024
Last Update
August 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Menoufia University
Cairo, Governorate, Egypt, 32511